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SUMMARY
Objective: To assess quantitative real-time polymerase chain reaction (q-PCR) for the sputum smear diagnosis of pulmonary 
tuberculosis (PTB) in patients living with HIV/AIDS with a clinical suspicion of PTB. Method: This is a prospective study to assess 
the accuracy of a diagnostic test, conducted on 140 sputum specimens from 140 patients living with HIV/AIDS with a clinical 
suspicion of PTB, attended at two referral hospitals for people living with HIV/AIDS in the city of Recife, Pernambuco, Brazil. A 
Löwenstein-Jensen medium culture and 7H9 broth were used as gold standard. Results: Of the 140 sputum samples, 47 (33.6%) 
were positive with the gold standard. q-PCR was positive in 42 (30%) of the 140 patients. Only one (0.71%) did not correspond to 
the culture. The sensitivity, specificity and accuracy of the q-PCR were 87.2%, 98.9% and 95% respectively. In 39 (93%) of the 42 
q-PCR positive cases, the CT (threshold cycle) was equal to or less than 37. Conclusion: q-PCR performed on sputum smears from 
patients living with HIV/AIDS demonstrated satisfactory sensitivity, specificity and accuracy, and may therefore be recommended 
as a method for diagnosing PTB. 
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INTRODUCTION
Infection by the human immunodeficiency virus (HIV) is an important 
risk factor in the development of tuberculosis (TB). HIV increases not 
only the risk of reactivating latent Mycobacterium tuberculosis (MTB) 
but also the re-infection of the disease7. The annual risk of progressing to 
TB amongst coinfected patients varies between five and 15%, depending 
on the degree of immunosuppression, against 0.5% and 1% in non-
coinfected patients12. 
In most cases, pulmonary tuberculosis (PTB) in those living with 
HIV/AIDS presents itself in an atypical clinical form, and from a clinical 
or radiological viewpoint is very often indistinguishable from other 
opportunistic infections7. 
Conventional laboratory techniques used for diagnosing PTB, such 
as the sputum smear test by Ziehl-Neelsen staining, which despite being 
inexpensive, presents low sensitivity since most coinfected patients have 
paucibacillary diseases9,16,17. Although the culture has a greater sensitivity 
of between 19 and 96%, and a specificity of 100%, and is the gold 
standard, it takes between four and eight weeks to obtain results13,15,16. 
In daily practice, it is common to prescribe anti-TB drugs for patients 
living with HIV/AIDS, without any confirmation of TB-disease, due to 
diagnostic difficulties and severity of symptoms. This conduct frequently 
leads to complications, not only due to the toxicity of anti-TB drugs, but 
also because of the interaction between these drugs and antiretroviral 
therapy (ART).
Studies have suggested that the inclusion of quantitative real-time 
polymerase chain reaction (q-PCR) is a method that may assist in 
diagnosing a variety of infections, including that caused by MTB5,6,8,10. 
q-PCR eliminates the gel electrophoresis steps in order to assess the 
results. Thus, it is a quicker, more sensitive technique, which also presents 
a lower risk of causing environmental contamination6,8. 
The aim of the present study is to assess q-PCR’s effectiveness in 
confirming a diagnosis of PTB in sputum from patients living with HIV/
AIDS and with a clinical suspicion of PTB.
METHODOLOGY
This was a prospective study to assess the accuracy of a diagnostic 
test, conducted between August 2009 and January 2012. A total of 
140 patients were included in the study who were aged 18 and over, 
HIV-infected and with a clinical suspicion of PTB, and who were 
attending two referral hospitals for HIV/AIDS in the city of Recife, 
Pernambuco, Brazil. Patients were excluded from the study if they were 
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taking anti-TB drugs or were unable to provide sputum samples for 
the study.
All patients tested HIV-positive, which was conducted by enzyme 
immunoassay (ELISA, Abbott Laboratories) and confirmed by 
immunofluorescence or Western blot, as required by the Ministry of 
Health (Ordinance No. 59). 
A sputum sample was collected from each patient. With patients who 
were unable to produce sputum spontaneously, sputum induction was 
performed with nebulized 3% hypertonic saline, for 20 minutes, with 
the aim of obtaining suitable material for the tests2,14. Collected data was 
stored in the study’s database. 
Sputum decontamination was undertaken with the NaOH-N-acetyl 
cysteine method. With the obtained sediment, slides were prepared for 
direct testing, performed with the Ziehl-Neelsen staining technique, and 
seeded in Löwenstein-Jensen solid medium (LJ (Difco-USA)) and 7H9 
broth (Becton-Dickinson Co. MD-USA). The remaining sediment was 
maintained at -80 oC until the q-PCR was conducted to identify the DNA 
of the MTB complex. 
The cultivated material was examined twice per week during the first 
two weeks and once per week over the course of eight weeks. The culture, 
gold standard, was considered positive when at least one of the media 
presented mycobacterial growth. Furthermore, to confirm the identity 
of the species M. tuberculosis within the MTB complex, a commercial 
niacin accumulation test was performed (Becton, Dickinson).
The q-PCR methodology used was previously published by 
LEMAITRE et al.10 and involved:
Step 1: Extraction of DNA from sputum: Tissue Protocol using 
the QIAamp DNA mini kit, following manufacturer’s recommendations, 
manufactured by Qiagen, Hilden, Germany.
Step 2: DNA Amplification: In summary: Primers and probes 
were used for IS6110 (Gene Bank No. X52471), designed from 
Primer Express Software, 2.0 (BIOSYTEMS), obtained from Applied 
Biosystems, Warrington, UK. The nucleotide sequences of the primers 
were: 5’- CCGAGGCAGGCATCCA-3’ (position 1062 to 1077) and 
5’-GATCGTCTCGGCTAGTGCATT-3’ (position 1112 to 1132). The 
sequence of the probe was 5’-FAM-TCGGAAGCTCCTATGAC-MGB-3’ 
(position 1095 to 1111). 
PCR amplification was performed in triplicate with a total volume of 
25 µL containing the TaqMan Universal PCR master mix 2X (Applied 
Biosytems), with 300 nM of each primer, 200 nM probe and 5 µL of 
extracted DNA. A BioRad iCycler IQ 5 Thermal Cycler was used, with 
the following conditions: two minutes at 50 ºC, 10 minutes at 95ºC and 
50 cycles at 95 ºC for 15 seconds and 60 ºC for one minute. The q-PCR 
was analyzed with Bio-Rad iQ5 1.0 software. For each reaction, positive 
and negative controls were used. 
All positive culture tests for mycobacteria and q-PCR negative tests 
for MTB were submitted to the q-PCR test to identify MTB complexes, 
M.avium-intracellulare, M.chelonae/abscessus and M.kansasi, using 
primers and probes designed by LEUNG et al.11
Patients were assessed at the moment of collecting the material, 
reassessed after the culture results, observing the response to anti-TB 
treatment. 
In order to undertake data analysis, rates were obtained for sensitivity, 
specificity, positive predictive values, negative predictive values and 
accuracy. The Kappa index was used to compare the LJ and 7H9 media. 
The Pearson’s chi-squared test was used to assess the association between 
categorical variables; a 5% margin of error. The program used for typing 
in all data and for obtaining the calculations was SPSS 17.
The present study was approved by the Ethics Committee at the 
Centro de Ciências da Saúde at Universidade Federal de Pernambuco 
(UFPE), Protocol No. 01.470.172.000-09
RESULTS
A total of 140 sputum specimens from 140 patients living with 
HIV/AIDS with a clinical suspicion of PTB were analyzed. Of these, 
47 (33.6%) were confirmed by culture, and 78 (55.7%) were male. Ages 
ranged from 19 to 64 years, a mean age of 37.13 years, a median of 36 
years and a standard deviation of 9.86 years.
In 37 (26.4%) of the 140 patients, the direct sputum test with Ziehl-
Neelsen staining was positive. Sensitivity, specificity, positive predictive 
value (PPV), negative predictive value (NPV) and accuracy of the direct 
test was 78.7%, 100%, 100%, 90.3% and 92.8%, respectively (Table 1).
q-PCR was positive in 42 (30%) of the 140 patients. Sensitivity, 
specificity, PPV, NPV and accuracy of the q-PCR were respectively: 
87.2%, 98.9%, 97.6%, 93.9% and 95% (Table 1).
Of the 42 patients with positive q-PCR results, 39 (93%) presented 
a threshold cycle (Ct) equal to or less than 37. The sensitivity of the 
q-PCR, considering this Ct value as indicative of positivity, was 92.3%, 
the PPV was 97.5% and the accuracy was 92.9%. It was not possible to 
determine the specificity and NPV due to the low frequency (one case) of 
negative results, when compared to the culture, the gold standard method.
The CD4 T-cell count varied between two and 1301 cells/mm3 
presenting a median value of 148.50. No statistically significant difference 
was observed between the q-PCR results and the value of the CD4 cells, 
p = 0.952 (Pearson chi-squared test).
DISCUSSION
Of the 140 patients studied with a clinical suspicion of PTB, only 47 
(33.6%) confirmed PTB with culture, the gold standard method. However, 
anti-TB treatment was initiated in 75 (53.6%) patients, 28 (20%) of whom 
initiated treatment without diagnostic confirmation. According to the 
reviewed medical records a therapeutic response to anti-TB treatment was 
observed in just eight (5.7%) of these patients and they were considered 
PTB cases with a negative culture. Due to the high frequency and severity 
of this coinfection, as well as the difficulty of arriving at a diagnosis 
with culture empirical treatment for TB is not uncommon in patients 
living with HIV/AIDS and respiratory symptoms. However, this conduct 
does not always prove beneficial, since coinfected patients present more 
adverse reactions to anti-TB drugs3. Moreover, there may be an interaction 
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between the anti-TB drugs and antiretroviral therapy, which may impose 
limitations on the therapeutic response of these patients. These facts 
reinforce the importance of a rapid, safe diagnostic test, so as to reduce 
the number of these unnecessary treatments.
The sensitivity and specificity of the direct test were 78.7% and 
100% respectively, where sensitivity was higher and specificity similar 
to other studies. In the direct test, KIBIKI et al. 2007 encountered a 
sensitivity of 66%, while REWATA et al. 2009, encountered 66.7% and 
SCHERER et al. 2011, 60%. The PPV and NPV of the direct test were 
100% and 90.3% respectively. The PPV was similar and the NPV was 
higher to that encountered by REWATA et al. 2009, who obtained a NPV 
of 83.3%. The high sensitivity of the direct test in the present study is 
probably related to the method of obtaining the sputum samples. The 
sputum induction technique was used for 26 (18.6%) patients who were 
complaining of a dry cough. Induced sputum samples are of good quality, 
similar to those obtained with bronchoalveolar lavage (BAL) obtained 
by bronchoscopy2,14. Furthermore, the direct test was conducted after 
sputum decontamination and subsequent centrifugation, which may have 
contributed to the test’s greater sensitivity. 
The q-PCR demonstrated a sensitivity and specificity of 87.2% and 
98.9%, respectively. These findings were similar to those of KIBIKI et 
al. 2007, who performed q-PCR with the BAL of patients living with 
HIV/AIDS. In KIBIKI’s study, the results for sensitivity were 85.7% and 
96.4% and for specificity were 52.3% and 90.9% with Ct values of 32 
and 40. It is important to emphasize that the present study used sputum 
in the q-PCR assessment, while KIBIKI et al. 2007, used BAL. Since 
similar results were obtained, this would suggest that sputum induction 
using a nebulizer is equivalent to BAL, demonstrating how this procedure 
could be useful in regions where it is difficult to perform a bronchoscopy.
Of the 42 positive q-PCRs, only one was not confirmed by culture, this 
patient supplied a relatively substantial amount of M. tuberculosis DNA 
(Ct = 35) and a satisfactory response to anti-TB treatment, suggesting a 
failure of the culture. In fact, the sensitivity of the culture, despite being 
gold standard, may not be so high in paucibacillary patients. The sensitivity 
of the culture in coinfected patients varies between 19 and 96%15.
The population levels of CD4 T-cells cannot be related to the results 
of the q-PCR. This demonstrates the usefulness of this test for diagnosing 
PTB at all stages of HIV infection. In patients with advanced AIDS, with 
low CD4 counts, PTB appears in an atypical form, and may be confused 
with several other infections12. The early, effective diagnosis of PTB is 
essential in order to ensure proper patient care, as well as reducing the 
transmission of MTB1.
It may be concluded that q-PCR, performed on sputum samples 
obtained either spontaneously or after induction, yields satisfactory 
levels of sensitivity, specificity and accuracy. Thus, given that q-PCR is 
a quick technique, it is recommended for routine use in the management 
of patients living with HIV/AIDS. 
RESÚMEN
Reacción en cadena de polimerasa en tiempo real cuantitativa 
(qPCR) para el diagnóstico de tuberculosis pulmonar en esputo de 
pacientes con VIH/sida
Objetivo: Evaluar la Reacción en Cadena de Polimerasa en tiempo 
real cuantitativa (qPCR) para el diagnóstico de tuberculosis pulmonar 
(TBP) en esputo de pacientes con sida y sospecha clínica de TBP. 
Método: Se trata de un estudio prospectivo para evaluación de precisión 
de prueba diagnóstica, realizado en 140 muestras de esputo provenientes 
de 140 pacientes con sida y sospecha clínica de TBP atendidos en dos 
hospitales de referencia para atención VIH/sida en Recife-PE, Brasil. 
Se utilizó el cultivo en medios Löwenstein-Jensen y 7H9 como estándar 
de oro. Resultados: De las 140 muestras de esputo, 47 (33,6%) fueron 
positivas por el estándar de oro. La qPCR fue positiva en 42 (30%) de los 
pacientes. En apenas un (0.71%) caso no correspondió con el cultivo. La 
sensibilidad, especificidad y precisión de la qPCR fueron 87,2%, 98,9% 
y 95% respectivamente. De las 42 qPCR positivas en 39 (93%) el CT 
(threshold cycle) fue igual o inferior a 37. Conclusión: La qPCR realizada 
en muestra de esputo de pacientes con sida demostró sensibilidad, 
especificidad y precisión satisfactoria, pudiendo ser recomendada como 
método de diagnóstico de TBP.
Table 1 
Comparison between qPCR and the direct test with the results of the culture (gold standard): sensitivity (S), specificity (Sp), positive predictive value (PPV), negative 
predictive value (NPV) and accuracy (A)
Test
Gold standard
Total
Percentage measurements 
Positive Negative S Sp PPV NPV A
• PCR-1
    Positive 41 1 42 87.2 98.9 97.6 93.9 95.0
    Negative 6 92 98
    Total 47 93 140
• BAAR
    Positive 37 - 37 78.7 100.0 100.0 90.3 92.8
    Negative 10 93 103
    Total 47 93 140
(1): PCR was only positive in 42 patients.
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